-->
membre depuis:
Portefeuille démarré:
Dernière connexion:
07-03-17
16-08-19
27-05-22 09:47
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
27/05/22 | ADVICENNE | Achat | 2 000 E | 5.66 | 5.55 | -2.34% | -47 | 6 | |
26/05/22 | ADVICENNE | Achat | 2 000 E | 5.16 | 5.55 | 7.14% | 143 | 6 | |
20/12/21 | ADVICENNE | Achat | 5 000 E | 8.34 | 5.55 | -33.79% | -1 690 | 8 | |
20/12/21 | ADVICENNE | Achat | 4 000 E | 8.34 | 5.55 | -33.79% | -1 352 | 3 | |
29/10/21 | ADVICENNE | Achat | 2 000 E | 9.86 | 5.55 | -44.02% | -880 | 7 | |
29/10/21 | ADVICENNE | Achat | 3 000 E | 9.87 | 5.55 | -44.08% | -1 322 | 5 | |
17/03/21 | PROLOGUE | Achat | 2 000 E | 0.42 | 0.28 | -33.50% | -670 | 10 | |
25/02/21 | ADVICENNE | Achat | 2 000 E | 14.90 | 5.55 | -62.89% | -1 258 | 13 | |
25/02/21 | ADVICENNE | Achat | 1 750 E | 14.90 | 5.55 | -62.89% | -1 101 | 12 | |
04/02/21 | PROLOGUE | Achat | 2 000 E | 0.39 | 0.28 | -28.38% | -568 | 28 | |
03/02/21 | PROLOGUE | Achat | 2 500 E | 0.40 | 0.28 | -30.17% | -754 | 60 | |
25/01/21 | PIXIUM VISION | Achat | 5 000 E | 1.00 | 0.24 | -76.12% | -3 806 | 27 | |
04/01/21 | PIXIUM VISION | Achat | 1 800 E | 0.82 | 0.24 | -70.99% | -1 278 | 64 | |
03/12/20 | MEMSCAP | Achat | 2 000 E | 1.09 | 1.17 | 6.92% | 138 | 28 | |
19/11/20 | NAVYA | Achat | 2 000 E | 2.74 | 0.31 | -88.91% | -1 778 | 23 | |
23/10/20 | OSE IMMUNOTHERAPEUTICS | Achat | 7 000 E | 7.14 | 7.23 | 0.86% | 60 | 86 | |
23/10/20 | GENOMIC VISION | Achat | 4 000 E | 0.88 | 0.10 | -88.86% | -3 554 | 97 | |
13/08/20 | LOGIC INSTRUMENT SA | Achat | 8 000 E | 0.52 | 0.31 | -40.54% | -3 243 | 16 | |
07/04/20 | EUROPCAR MOBILITY GROUP | Achat | 3 500 E | 1.84 | 0.51 | -72.41% | -2 534 | 30 | |
07/04/20 | MAUNA KEA TECHNOLOGIES | Achat | 2 000 E | 1.00 | 0.79 | -21.18% | -424 | 194 | |
03/04/20 | TECHNIPFMC | Achat | 5 000 E | 6.98 | 5.91 | -15.51% | -776 | 62 | |
09/03/20 | COFIDUR SA | Achat | 8 000 E | 270.76 | 354.00 | 30.51% | 2 441 | 167 | |
14/02/20 | CROSSJECT | Achat | 8 000 E | 2.57 | 3.99 | 55.00% | 4 400 | 227 | |
16/01/20 | INTEGRAGEN | Achat | 8 000 E | 1.18 | 1.29 | 8.90% | 712 | 24 | |
13/01/20 | OSE IMMUNOTHERAPEUTICS | Achat | 9 060 E | 3.90 | 7.23 | 84.81% | 7 684 | 21 | |
Enregistrements 1 à 25 sur 25 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
26/01/22 | SMCP SA | Achat | 4 000 E | 6.36 | 7.30 | 14.57% | 583 | 15 | |
17/03/21 | CGG | Achat | 2 800 E | 0.92 | 1.11 | 20.43% | 572 | 254 | |
17/03/21 | CGG | Achat | 5 000 E | 0.85 | 1.11 | 30.36% | 1 518 | 12 | |
17/03/21 | CGG | Achat | 2 500 E | 0.81 | 1.11 | 36.80% | 920 | 13 | |
15/03/21 | O2I | Achat | 1 000 E | 1.07 | 1.06 | -1.13% | -11 | 13 | |
11/03/21 | MEMSCAP | Achat | 1 800 E | 0.99 | 1.69 | 70.17% | 1 263 | 35 | |
16/02/21 | GROUPE SFPI | Achat | 500 E | 0.97 | 1.85 | 90.43% | 452 | 24 | |
28/12/20 | PHARMASIMPLE SA | Achat | 8 000 E | 6.17 | 10.40 | 68.02% | 5 442 | 191 | |
02/12/20 | GROUPE SFPI | Achat | 1 500 E | 0.92 | 1.62 | 75.81% | 1 137 | 39 | |
16/10/20 | ENERTIME | Achat | 5 000 E | 1.37 | 1.35 | -1.86% | -93 | 26 | |
10/06/20 | COFIDUR SA | DIV | 0 E | 0.00 | 8.00 | 0.00% | 236 | 24 | |
01/06/20 | GROUPE SFPI | Achat | 3 500 E | 1.01 | 1.23 | 21.56% | 755 | 15 | |
01/06/20 | GROUPE SFPI | Achat | 3 000 E | 0.91 | 1.23 | 34.93% | 1 048 | 20 | |
01/06/20 | GROUPE SFPI | Achat | 3 200 E | 1.01 | 1.23 | 21.56% | 690 | 12 | |
01/06/20 | GROUPE SFPI | Achat | 987 E | 0.98 | 1.23 | 25.28% | 250 | 16 | |
14/04/20 | INTEGRAGEN | Achat | 4 000 E | 1.25 | 1.70 | 35.76% | 1 430 | 12 | |
08/04/20 | GROUPE SFPI | Achat | 3 500 E | 0.95 | 1.04 | 9.26% | 324 | 13 | |
31/03/20 | GROUPE SFPI | Achat | 8 000 E | 0.97 | 1.03 | 5.98% | 478 | 18 | |
30/03/20 | GROUPE SFPI | Achat | 8 000 E | 0.94 | 1.01 | 7.24% | 579 | 29 | |
30/03/20 | GROUPE SFPI | Achat | 2 478 E | 0.95 | 1.01 | 6.11% | 151 | 8 | |
14/02/20 | THERADIAG | Achat | 5 000 E | 1.51 | 1.70 | 12.37% | 619 | 36 | |
16/01/20 | KERLINK | Achat | 7 999 E | 1.08 | 8.41 | 677.83% | 54 220 | 133 | |
Enregistrements 1 à 22 sur 22 |